NLRP3 and brain ischemia: Wang et al. found that inhibition of GSK-3β could downregulate NLRP3 expression by enhancing autophagy activity in cerebral ischemia-reperfusion injury, suggesting that GSK-3β may be its specific target (Wang et al., 2019).